fashion -WSS

fashion

author：knowledge 2025-10-01 20:13:47 - browse：5

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Will General Catalyst be the first of many hospital takeovers?

WSS

Indian pharmaceutical industry in denial over drug

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Free speech concerns arise in wake of journal editor Eisen's firing

UCSF medical school apologizes for unethical prisoner experiments

Tocagen's brain cancer gene therapy trial continues. Investors worry

EF3 tornado rips through North Carolina amid extreme weather nationwide

explore

fashion

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Sacklers, horror, and ‘The Fall of the House of Usher’

Guidelines to prevent youth baseball injuries need more muscle

STAT Executive Editor Rick Berke on STAT's 8th birthday

New air purifier tech could be key to improving indoor air quality

Free speech concerns arise in wake of journal editor Eisen's firing

Hepatitis C has a cure — but many Americans still lack access to it

7 more heat

Supreme Court strikes down use of affirmative action

Sanofi CEO defends move to abandon profit guidance, boost research

Wikipedia

Will General Catalyst be the first of many hospital takeovers?

Medicare will require more price transparency from hospitals

Senate panel clears PBM, hopsital reforms

Ending racial health disparities hinges on penalties, political will

Removing probiotics from the NICU could threaten preemies' health

Judge rejects Trump's request to move Stormy Daniels hush

Wikipedia

knowledge

explore

explore